The MD Anderson Symptom Inventory Spine Tumor Module (MDASI-SP)



MD Anderson Symptom Inventory (MDASI) modules augment the 19 core MDASI symptom and interference items with additional items identified as unique to a particular patient population. MDASI modules may be disease-specific, disease-site-specific, or treatment-specific.

The MDASI-SP is a site-specific module. Along with the core MDASI’s 13 symptom items and 6 interference items, the MDASI-SP also assesses 5 symptoms specific to spine cancer: 

  • radiating spine pain
  • weakness in the arms and/or legs
  • loss of control of bowel and/or bladder
  • changes in bowel pattern (diarrhea or constipation)
  • sexual dysfunction

MDASI-SP Features

  • Purpose: To assess the severity of multiple spine cancer-related symptoms and the impact of these symptoms on daily functioning
  • Population: Patients with symptoms caused by spine cancer and its treatment
  • Assessment areas: Severity of multiple symptoms and the impact of symptoms on daily functioning during the last 24 hours
  • Method: Self-report; paper-and-pencil form or tablet PC (self-administered or via interview), or telephone-based interactive voice response (IVR) system
  • Time required: Five minutes
  • Scoring: Please see the MDASI User's Guide
  • Reliability: Cronbach alpha reliability ranges from 0.71 to 0.95

MDASI-SP Language Versions

The MDASI-SP is available in the languages shown below. Click on a linked language to view a sample in PDF format.

Psychometrically and Linguistically ValidatedLinguistically Validated

Future Validation Studies: We would like to collaborate with other investigators to develop and validate new language versions of the MDASI-SP. Contact us for more information. NOTE: The MDASI-SP may not be modified or translated into another language without express written consent (see Notice of Copyright below).

To Order the MDASI-SP

To use the MDASI-SP in a publication or clinical or research trial, you must obtain permission by filling out our order form and you must comply with the copyright. Fees may apply:

Type of UseFirst Language Version (Per Project)Additional Language Versions (Per Project)
Non-funded academic researchNo chargeNo charge
Individual clinical practiceNo chargeNo charge
Funded academic research$300$150
Commercial research$2,000$1,200

The MDASI-SP will be e-mailed to you as a PDF file within 7 to 10 business days. If your request is urgent or the language version you seek is not shown, contact us to make special arrangements:

Department of Symptom Research
Attn: Assessment Tools
The University of Texas MD Anderson Cancer Center
1515 Holcombe Boulevard, Unit 1450
Houston, Texas 77030  

If applicable, an invoice will be e-mailed to you. Reference the invoice number on your payment and include on the memo line, "MD Anderson Assessment Tool Distribution."

Notice of Copyright

The M. D. Anderson Symptom Inventory (MDASI) copyright is held by The University of Texas MD Anderson Cancer Center and administered by the MDASI's developer, Charles S. Cleeland, PhD. The copyright applies to the MDASI, its modules, and all its derivatives in any language.

The MDASI-SP may not be used or reproduced without permission from Charles S. Cleeland, PhD, or his designee. Fees for use may apply (see above).

The MDASI and its modules may not be modified or translated into another language without the express written consent of the copyright holder. Failure to comply may result in legal action. Contact us via e-mail at or at the address shown above to obtain permission to alter or translate the instrument.

Selected References


Armstrong TS, Gning I, Mendoza TR, Vera-Bolanos E, Gilbert MR, Rhines LD, Weinberg JS, Sanchez-Williams G, Levin V, Burton AW, Cleeland C. Reliability and validity of the M. D. Anderson Symptom Inventory-Spine Tumor Module. J Neurosurg Spine 12(4): 421-430, 2010.

Cleeland CS, Mendoza TR, Wang XS, Chou C, Harle M, Morrissey M, Engstrom MC. Assessing Symptom Distress in Cancer: The M. D. Anderson Symptom Inventory. Cancer 89:1634-1646, 2000.

Related News

Symptom Research hosts national colloquium on developing strategies for reducing cancer treatment-related toxicities and symptoms. Read more...

 Cancer Symptom Science

Announcing the publication of Cancer Symptom Science, an interdisciplinary, first-of-its-kind compilation of research on the mechanisms underlying the expression of cancer-related symptoms. Read more...

Old Drugs, New Possibilities (Conquest, Fall 2008)

Symptom Research Awarded NIH P01 Grant (Division of Internal Medicine Newsletter, Summer 2008)

Symptom Research and Psychometrics (Network, Summer 2008)